Tuesday 5 November 2024

The Pharma Letter Podcast — Episode 9 — The rise of AI in drug discovery

Biotechnology
Simon Wentworth
30 December 2021
episode9-theriseofai

More on this story...

Pharmaceutical
European drugmakers embrace artificial intelligence
3 December 2020
Biotechnology
Biopharma and quantum computing tie-up a 'milestone for the entire industry'
5 January 2022
Pharmaceutical
The FDA and artificial intelligence
7 June 2021
Biotechnology
Biolojic Design inks multi-target drug collaboration with Merck
4 June 2024


Companies featured in this story

More ones to watch >


Today's issue

Nektar sells its PEGylation reagent manufacturing business
Biotechnology
Nektar sells its PEGylation reagent manufacturing business
5 November 2024
Pharmaceutical
PharmaMar gets $10 million milestone from Janssen for Yondelis
5 November 2024
Pharmaceutical
Photocure’s Hexvix wins Chinese approval
5 November 2024
Pharmaceutical
Vertex ups guidance again as results exceed estimates
5 November 2024
Biotechnology
Transgene and ProBioGen join forces on cancer vaccines
5 November 2024
Biotechnology
Nxera Pharma and Antiverse partner on GPCRs
5 November 2024
Pharmaceutical
Positive results for Neurocrine’s Ingrezza in tardive dyskinesia
5 November 2024

Company Spotlight

A Denmark-headquartered company that currently has a pipeline of three independent endocrinology rare disease product candidates in clinical development and is advancing oncology as its second therapeutic area of focus.




More Features in Biotechnology

Nektar sells its PEGylation reagent manufacturing business
5 November 2024
Transgene and ProBioGen join forces on cancer vaccines
5 November 2024
Nxera Pharma and Antiverse partner on GPCRs
5 November 2024
Frits van Alphen gets Memo CDO job
4 November 2024


Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze